SpectrumDNA Valuation

SPXA Stock  USD 0.01  0.00  0.00%   
SpectrumDNA seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of SpectrumDNA from inspecting the company fundamentals such as Current Valuation of 237.12 K, price to earning of (0.07) X, and Return On Equity of -13.03 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting SpectrumDNA's valuation include:
Enterprise Value
237.1 K
Enterprise Value Ebitda
(0.17)
Price Sales
4.8494
Enterprise Value Revenue
2.4882
Overvalued
Today
0.01
Please note that SpectrumDNA's price fluctuation is very steady at this time. Calculation of the real value of SpectrumDNA is based on 3 months time horizon. Increasing SpectrumDNA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SpectrumDNA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SpectrumDNA Stock. However, SpectrumDNA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0098 Real  0.008232 Hype  0.0098 Naive  0.0098
The real value of SpectrumDNA Stock, also known as its intrinsic value, is the underlying worth of SpectrumDNA Company, which is reflected in its stock price. It is based on SpectrumDNA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SpectrumDNA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.01
Real Value
0.01
Upside
Estimating the potential upside or downside of SpectrumDNA helps investors to forecast how SpectrumDNA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SpectrumDNA more accurately as focusing exclusively on SpectrumDNA's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Naive
Forecast
LowNext ValueHigh
0.010.010.01
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use SpectrumDNA's intrinsic value based on its ongoing forecasts of SpectrumDNA's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against SpectrumDNA's closest peers. If more than one evaluation category is relevant for SpectrumDNA we suggest using both methods to arrive at a better estimate.

SpectrumDNA Cash

167,474

About SpectrumDNA Valuation

The stock valuation mechanism determines SpectrumDNA's current worth on a weekly basis. Our valuation model uses a comparative analysis of SpectrumDNA. We calculate exposure to SpectrumDNA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SpectrumDNA's related companies.
Last ReportedProjected for Next Year
Gross Profit157.7 K165.6 K
Pretax Profit Margin(12.53)(13.16)
Operating Profit Margin(12.26)(12.87)
Net Loss(12.53)(13.16)
Gross Profit Margin 0.87  0.92 

SpectrumDNA Current Valuation Indicators

Valuation refers to the process of determining the present value of SpectrumDNA and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value SpectrumDNA we look at many different elements of the entity such as SpectrumDNA's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as SpectrumDNA, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use SpectrumDNA's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes SpectrumDNA's worth.

Complementary Tools for SpectrumDNA Stock analysis

When running SpectrumDNA's price analysis, check to measure SpectrumDNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectrumDNA is operating at the current time. Most of SpectrumDNA's value examination focuses on studying past and present price action to predict the probability of SpectrumDNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectrumDNA's price. Additionally, you may evaluate how the addition of SpectrumDNA to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.